# FDA 483 - Arifulla Khan MD - June 11, 2014

Source: https://www.globalkeysolutions.net/records/483/arifulla-khan-md/86776fd3-10ae-4872-aa64-fce0d73af6b9

> FDA 483 for Arifulla Khan MD on June 11, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Arifulla Khan MD
- Inspection Date: 2014-06-11
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: Arifulla Khan, M.D., a clinical investigator in Bellevue, WA, was cited for significant deficiencies in conducting clinical trials. The inspection revealed failures to adhere to investigational plans, including issues with contradictory subject eligibility documentation and improper management of investigational product non-compliance. Additionally, the firm failed to obtain proper informed consent and maintain accurate case histories, leading to critical data discrepancies.

## Related Officers

- [Senior Quality Engineer](https://www.globalkeysolutions.net/people/sharon-gundersen/5bc43dc9-a52b-4e19-b8c2-75fd37e8e175)
- [Marijo B. Kambere](https://www.globalkeysolutions.net/people/marijo-b-kambere/54e010f0-0d56-4b20-b5e2-112e372de58b)

Company: https://www.globalkeysolutions.net/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822